On World AIDS Day, SAMHSA renews commitment to end the HIV epidemic
Impact on your practice
This is a commemorative awareness piece highlighting the intersection of HIV, substance use, and mental health during the pandemic. No direct policy or reimbursement impact, but underscores SAMHSA's integrated care priorities.
Key facts
World AIDS Day 2020 theme: 'Ending the HIV/AIDS Epidemic: Resilience and Impact'
SAMHSA notes COVID-19 pandemic exacerbated challenges for people with HIV, SUD, and mental illness
Calls for renewed commitment to integrated care and pandemic resilience
Therapy Companion analysis
This SAMHSA statement signals a federal priority shift that will shape your grant funding, referral pathways, and documentation requirements if you work with substance use or mental health populations. If your practice receives SAMHSA funding or participates in their grantee networks, expect increased pressure to integrate HIV screening into routine intake and ongoing treatment. SAMHSA's stated goal—ensuring every beneficiary receives HIV testing and post-test counseling with linkage to treatment—means you'll need protocols in place for universal screening, even if HIV prevalence in your specific patient population appears low. The 2020 data showing SAMHSA grantees screened nearly 19,000 individuals and identified 577 new HIV cases demonstrates the scale of this initiative. For solo practitioners and small group practices not directly funded by SAMHSA, the impact is indirect but real: insurance panels increasingly expect integrated care documentation, and payers are aligning with federal priorities around HIV prevention in high-risk populations (people with SUD, mental illness, or both). You should anticipate that clinical notes will need to document HIV risk assessment and screening decisions, similar to how you now document suicide risk. If you refer patients to SAMHSA-funded treatment centers or community mental health centers, those partners will be implementing these screening protocols, and your referral documentation should reflect awareness of their HIV prevention focus. The emphasis on virtual delivery and alternative testing strategies (like oral fluid self-testing) suggests that telehealth-based practices can now offer HIV screening support without in-person lab draws, expanding your capacity to address this clinical domain.
Background
This December 2020 statement reflects SAMHSA's alignment with the federal 'Ending the Epidemic: A Plan for America' initiative, which launched in 2019 with the goal of reducing new HIV infections by 75% within five years and by 90% within ten years. The statement was issued during a critical moment when COVID-19 disrupted traditional service delivery, forcing SAMHSA grantees to rapidly adopt telehealth and alternative testing methods. The broader context is that people with untreated substance use disorder and mental illness face significantly elevated HIV risk due to high-risk injection practices, sexual behaviors during intoxication, and reduced access to prevention services. SAMHSA's framing of substance use treatment and mental health care as HIV prevention strategies—not just parallel services—represents a deliberate policy shift toward integrated screening and treatment. The pandemic accelerated this integration by forcing innovation in virtual testing and counseling, which has now become standard practice guidance. For therapists, this means the federal government is explicitly positioning mental health and SUD treatment as frontline HIV prevention infrastructure, which will influence funding priorities, training requirements, and performance metrics for organizations receiving federal dollars.
What you should do
Audit your current intake and ongoing assessment documentation to determine whether you are systematically documenting HIV risk assessment and screening decisions. If you work with populations at elevated risk (people with SUD, multiple sexual partners, history of incarceration, or untreated mental illness), add a standardized HIV risk screening question to your intake form and document the clinical reasoning for screening or deferral in every chart.
If your practice receives SAMHSA funding or contracts with SAMHSA-funded organizations, review the November 2020 publication 'Prevention and Treatment of HIV among People Living with Substance Use and/or Mental Disorders' and ensure your clinical protocols align with SAMHSA's integrated care model. This document will likely inform future grant compliance audits and performance metrics.
Establish a referral protocol for patients who screen positive or express HIV prevention interest. Know which local organizations offer PrEP services, HIV treatment, and post-test counseling. Document these referrals in your clinical notes to demonstrate linkage to care, which is now a federal performance indicator.
If you use telehealth, familiarize yourself with oral fluid HIV self-testing options and CDC guidance on remote HIV counseling. This expands your capacity to support HIV screening without requiring in-person lab draws and positions your practice as aligned with federal pandemic-resilience priorities.
Monitor your liability insurance and clinical supervision arrangements to ensure you are competent in HIV risk assessment and post-test counseling. If you are not trained in these areas, seek continuing education or establish a consultation relationship with an HIV specialist, particularly if you work with high-risk populations.
Notable excerpts
Treating substance use disorder and mental disorder is a form of HIV prevention. Substance use treatment centers and community mental health centers serve on the front lines of the HIV epidemic as important pathways to HIV testing, treatment for people who test positive, and prevention services.
Our eventual goal is to ensure that every beneficiary of SAMHSA programming receives an HIV test, post-test counseling, and linkage to treatment or prevention services.
SAMHSA's grantees and partner organizations have risen to the challenge, and developed innovative ways to deliver substance use disorder, mental disorder, and HIV testing and referrals in a largely virtual space.
View full source text
Policy changes drive denial patterns
Therapy Companion tracks both: the policy shifts on this page and the denial patterns hitting your claims.
Related policy changes
[MA] H4895: Expanding access to mental health services
This bill aims to expand mental health service access in Massachusetts and has cleared committee with a favorable recommendation. Depending on final language, it could affect reimbursement rates, telehealth authorization, or insurance coverage requirements.
[TN] SB1248: AN ACT to amend Tennessee Code Annotated, Title 4; Title 8; Title 33; Title 39; Title 49; Title 53; Title 56; Title 63; Title 68 and Title 71, relative to mental health.
This comprehensive TN mental health bill touches multiple code sections and could affect licensure, scope of practice, insurance requirements, and workforce regulations. Therapists should monitor its progress closely as it moves through committee.
Advancing the Future of Behavioral Health Data Exchange
This policy direction addresses a critical pain point for therapists: the lack of integrated health data exchange with primary care and medical providers. Improved interoperability could reduce documentation burden, improve care coordination, and reduce liability from medication interactions or missed diagnoses. However, it may also increase compliance requirements and data security obligations.
Opinion: MAHA is rewriting the vocabulary of American mental health care
Federal deprescribing initiatives create new clinical and billing opportunities for therapists while potentially pressuring prescribing practices. Therapists should understand the evidence, reimbursement rules, and ethical considerations around medication tapering to protect clients and navigate changing clinical norms.